scholarly journals Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study

Diabetes Care ◽  
2021 ◽  
pp. dc201712
Author(s):  
Maryam Saeed ◽  
German Tapia ◽  
Inger Ariansen ◽  
Lars C. Stene ◽  
Ingebjørg Seljeflot ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Type 1 Diabetes ◽  
Cohort Study ◽  
Heart Disease ◽  
Childhood Onset ◽  
Onset Type ◽  
Galectin 3 ◽  
Subsequent Risk

scholarly journals Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study

2021 ◽  
Author(s):  
Maryam Saeed ◽  
German Tapia ◽  
Inger Ariansen ◽  
Lars C. Stene ◽  
Ingebjørg Seljeflot ◽  
...  
Keyword(s):  
Risk Factors ◽  
Coronary Heart Disease ◽  
Type 1 Diabetes ◽  
Heart Disease ◽  
High Sensitivity ◽  
Childhood Onset ◽  
Onset Type ◽  
Galectin 3 ◽  
Conventional Risk Factors

<a><i>Objective:</i></a> To study whether serum galectin-3 and other biomarkers of inflammation predict coronary heart disease (CHD) in subjects with longstanding childhood-onset type 1 diabetes. <p><i>Research, design and methods:</i> A population-based nation-wide cohort of 299 subjects with type 1 diabetes diagnosed in Norway at age <15 years during 1973-1982. They were examined in 2002-2003 at mean age of 33 years (range 21-44), with mean diabetes duration of 24 years (range 19-30). Subjects were followed through December 31, 2017 for their first CHD event registered by a hospitalization or cause of death using nation-wide registries. Stored serum samples were available for 296 subjects and analyzed for interleukin (IL)-6, IL-6 receptor, IL-18, high sensitivity-C-reactive protein, matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, galectin-3 and high sensitivity troponin T (hs-TNT). Adjusted hazard ratios (aHR) for CHD per standard deviation increase in biomarker were estimated using Cox regression. </p> <p><i>Results:</i> Of 295 subjects, 40 (13.6%) had documented CHD event during mean follow-up of 14.4 years (range 0.5 - 16). IL-6 (aHR 1.32, 95% CI: 1.07 – 1.63), galectin-3 (aHR 1.44, 95% CI: 1.09 – 1.80) and TIMP-1 (aHR 1.37, 95% CI 1.04 – 1.81) were significant predictors of CHD after adjustment for conventional risk factors. </p> <p><i>Conclusion:</i><b> </b>Galectin-3 was significantly associated with future CHD in subjects with type 1 diabetes, and if the results are replicated in larger studies it may aid in prediction together with conventional risk factors for CHD. <b><br> </b></p>

scholarly journals Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study

2021 ◽  
Author(s):  
Maryam Saeed ◽  
German Tapia ◽  
Inger Ariansen ◽  
Lars C. Stene ◽  
Ingebjørg Seljeflot ◽  
...  
Keyword(s):  
Risk Factors ◽  
Coronary Heart Disease ◽  
Type 1 Diabetes ◽  
Heart Disease ◽  
High Sensitivity ◽  
Childhood Onset ◽  
Onset Type ◽  
Galectin 3 ◽  
Conventional Risk Factors

<a><i>Objective:</i></a> To study whether serum galectin-3 and other biomarkers of inflammation predict coronary heart disease (CHD) in subjects with longstanding childhood-onset type 1 diabetes. <p><i>Research, design and methods:</i> A population-based nation-wide cohort of 299 subjects with type 1 diabetes diagnosed in Norway at age <15 years during 1973-1982. They were examined in 2002-2003 at mean age of 33 years (range 21-44), with mean diabetes duration of 24 years (range 19-30). Subjects were followed through December 31, 2017 for their first CHD event registered by a hospitalization or cause of death using nation-wide registries. Stored serum samples were available for 296 subjects and analyzed for interleukin (IL)-6, IL-6 receptor, IL-18, high sensitivity-C-reactive protein, matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, galectin-3 and high sensitivity troponin T (hs-TNT). Adjusted hazard ratios (aHR) for CHD per standard deviation increase in biomarker were estimated using Cox regression. </p> <p><i>Results:</i> Of 295 subjects, 40 (13.6%) had documented CHD event during mean follow-up of 14.4 years (range 0.5 - 16). IL-6 (aHR 1.32, 95% CI: 1.07 – 1.63), galectin-3 (aHR 1.44, 95% CI: 1.09 – 1.80) and TIMP-1 (aHR 1.37, 95% CI 1.04 – 1.81) were significant predictors of CHD after adjustment for conventional risk factors. </p> <p><i>Conclusion:</i><b> </b>Galectin-3 was significantly associated with future CHD in subjects with type 1 diabetes, and if the results are replicated in larger studies it may aid in prediction together with conventional risk factors for CHD. <b><br> </b></p>

scholarly journals Increasing risk of psychiatric morbidity after childhood onset type 1 diabetes: a population-based cohort study

Diabetologia ◽  
2017 ◽  
Vol 61 (4) ◽  
pp. 831-838 ◽  
Author(s):  
Daniel Dybdal ◽  
Janne S. Tolstrup ◽  
Stine M. Sildorf ◽  
Kirsten A. Boisen ◽  
Jannet Svensson ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cohort Study ◽  
Psychiatric Morbidity ◽  
Population Based ◽  
Childhood Onset ◽  
Onset Type ◽  
Increasing Risk

scholarly journals Early deaths from ischaemic heart disease in childhood-onset type 1 diabetes

2018 ◽  
Vol 103 (10) ◽  
pp. 981-983 ◽  
Author(s):  
Trina C Evans-Cheung ◽  
H Jonathan Bodansky ◽  
Roger C Parslow ◽  
Richard G Feltbower
Keyword(s):  
Type 1 Diabetes ◽  
Heart Disease ◽  
Ischaemic Heart Disease ◽  
Clinical Validation ◽  
Death Certification ◽  
Childhood Onset ◽  
Children And Young People ◽  
Onset Type ◽  
Standardised Mortality Ratios

AimsThe risk of ischaemic heart disease (IHD) death in early type 1 diabetes onset was assessed using death certification data.MethodsThe Yorkshire Register of type 1 Diabetes in Children and Young People was linked to clinically validated death certification data for those diagnosed under 15 years. Standardised mortality ratios (SMRs) were calculated using the England and Wales population and IHD death rates between 1978 and 2014 by 5-year age group and sex.ResultsThe cohort included 4382 individuals (83 097 person years). Of 156 deaths, nine were classed as IHD deaths before clinical validation. After clinical validation, 14 IHD deaths were classified, with an SMR of 13.8 (95% CI 8.2 to 23.3) and median age at death of 35.1 years (range 21.9–47.9 years).ConclusionsThere is an early emergence of death from IHD in early onset type 1 diabetes. Underascertainment of IHD deaths was present without clinical validation of death certification.

Transition and beyond in childhood onset type 1 diabetes

2014 ◽  
Author(s):  
Suma Uday ◽  
James Yong ◽  
Fiona Campbell ◽  
Ramzi Ajjan
Keyword(s):  
Type 1 Diabetes ◽  
Childhood Onset ◽  
Onset Type
Sign in / Sign up

Export Citation Format

Share Document